Financial & SEC Reports

Here you will find a summary of Celldex Therapeutics, Inc.'s latest financial information.

Latest 10-Q

There are no SEC filings available.

Latest Annual Report and 10-K

Latest Proxy Statement

There are no SEC filings available.

Copyright Morningstar

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline